The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tassi, I.
Right arrow Articles by Colonna, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tassi, I.
Right arrow Articles by Colonna, M.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Substance via MeSH
The Journal of Immunology, 2005, 175: 749-754.
Copyright © 2005 by The American Association of Immunologists

Phospholipase C-{gamma}2 Is a Critical Signaling Mediator for Murine NK Cell Activating Receptors1

Ilaria Tassi*, Rachel Presti*, Sungjin Kim{dagger}, Wayne M. Yokoyama{dagger}, Susan Gilfillan* and Marco Colonna2,*

* Department of Pathology and Immunology, and {dagger} Department of Medicine and Howard Hughes Medical Institute, Washington University School of Medicine, St Louis, MO 63110

Phospholipase C-{gamma} (PLC{gamma}) is a key regulator of intracellular Ca2+ mobilization. Two isoforms of PLC{gamma} have been identified, PLC{gamma}1 and PLC{gamma}2. Previously, in vitro studies indicated that activating NK cell receptors signal through both isoforms. However, PLC{gamma}2 deficiency alone was sufficient to induce a substantial impairment of NK cell-mediated cytotoxicity in vitro. Why PLC{gamma}2 is more important than PLC{gamma}1 for NK cell activation and whether PLC{gamma}2 is also critical for NK cell development, secretion of IFN-{gamma}, and clearance of viral infections in vivo is not known. In this study, we report that PLC{gamma}2 is the predominant isoform expressed in murine NK cells. PLC{gamma}2 deficiency did not affect NK cell numbers in bone marrow and spleen, but acquisition of Ly49 receptors by NK cells was partially impaired. PLC{gamma}2-deficient NK cells exhibited a dramatic impairment of cytolytic function and IFN-{gamma} production upon ligation of activating receptors, whereas they did secrete IFN-{gamma} in response to cytokines. Consequently, mice lacking PLC{gamma}2 controlled murine CMV infection substantially less effectively than did wild-type animals, and this defect was most evident in the spleen, where viral clearance mostly depends on NK cell lytic function. These results demonstrate that PLC{gamma}2 is crucial for development of the NK cell receptor repertoire and signaling of activating NK cell receptors, mediating optimal NK cell function in vivo.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
N. G. Clarkson and M. H. Brown
Inhibition and Activation by CD244 Depends on CD2 and Phospholipase C-{gamma}1
J. Biol. Chem., September 11, 2009; 284(37): 24725 - 24734.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
I. Tassi, M. Cella, R. Presti, A. Colucci, S. Gilfillan, D. R. Littman, and M. Colonna
NK cell-activating receptors require PKC-{theta} for sustained signaling, transcriptional activation, and IFN-{gamma} secretion
Blood, November 15, 2008; 112(10): 4109 - 4116.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Chen, X. Wang, L. Di, G. Fu, Y. Chen, L. Bai, J. Liu, X. Feng, J. M. McDonald, S. Michalek, et al.
Phospholipase C{gamma}2 Mediates RANKL-stimulated Lymph Node Organogenesis and Osteoclastogenesis
J. Biol. Chem., October 24, 2008; 283(43): 29593 - 29601.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
G. C. Whittaker, D. N. Burshtyn, S. J. Orr, L. Quigley, D. L. Hodge, V. Pascal, W. Zhang, and D. W. McVicar
Analysis of the linker for activation of T cells and the linker for activation of B cells in natural killer cells reveals a novel signaling cassette, dual usage in ITAM signaling, and influence on development of the Ly49 repertoire
Blood, October 1, 2008; 112(7): 2869 - 2877.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
H. Guo, A. Samarakoon, B. Vanhaesebroeck, and S. Malarkannan
The p110{delta} of PI3K plays a critical role in NK cell terminal maturation and cytokine/chemokine generation
J. Exp. Med., September 29, 2008; 205(10): 2419 - 2435.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
B. Hernandez-Novoa, L. Bishop, C. Logun, P. J. Munson, E. Elnekave, Z. G. Rangel, J. Barb, R. L. Danner, and J. A. Kovacs
Immune responses to Pneumocystis murina are robust in healthy mice but largely absent in CD40 ligand-deficient mice
J. Leukoc. Biol., August 1, 2008; 84(2): 420 - 430.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. W. MacFarlane IV, T. Yamazaki, M. Fang, L. J. Sigal, T. Kurosaki, and K. S. Campbell
Enhanced NK-cell development and function in BCAP-deficient mice
Blood, July 1, 2008; 112(1): 131 - 140.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
F. Micucci, C. Capuano, E. Marchetti, M. Piccoli, L. Frati, A. Santoni, and R. Galandrini
PI5KI-dependent signals are critical regulators of the cytolytic secretory pathway
Blood, April 15, 2008; 111(8): 4165 - 4172.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. D. Coudert, L. Scarpellino, F. Gros, E. Vivier, and W. Held
Sustained NKG2D engagement induces cross-tolerance of multiple distinct NK cell activation pathways
Blood, April 1, 2008; 111(7): 3571 - 3578.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
S. Hidano, H. Sasanuma, K. Ohshima, K.-i. Seino, L. Kumar, K. Hayashi, M. Hikida, T. Kurosaki, M. Taniguchi, R. S. Geha, et al.
Distinct regulatory functions of SLP-76 and MIST in NK cell cytotoxicity and IFN-{gamma} production
Int. Immunol., March 1, 2008; 20(3): 345 - 352.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
V. Pascal, N. R. Nathan, E. Claudio, U. Siebenlist, and S. K. Anderson
NF-{kappa}B p50/p65 Affects the Frequency of Ly49 Gene Expression by NK Cells
J. Immunol., August 1, 2007; 179(3): 1751 - 1759.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. H. Johansson, M. A. Taylor, M. Jagodic, K. Tus, J. D. Schatzle, E. K. Wakeland, and M. Bennett
Mapping of Quantitative Trait Loci Determining NK Cell-Mediated Resistance to MHC Class I-Deficient Bone Marrow Grafts in Perforin-Deficient Mice
J. Immunol., December 1, 2006; 177(11): 7923 - 7929.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Regunathan, Y. Chen, S. Kutlesa, X. Dai, L. Bai, R. Wen, D. Wang, and S. Malarkannan
Differential and Nonredundant Roles of Phospholipase C{gamma}2 and Phospholipase C{gamma}1 in the Terminal Maturation of NK Cells
J. Immunol., October 15, 2006; 177(8): 5365 - 5376.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
H. Sasanuma, A. Tatsuno, S. Hidano, K. Ohshima, Y. Matsuzaki, K. Hayashi, C. A. Lowell, D. Kitamura, and R. Goitsuka
Dual function for the adaptor MIST in IFN-{gamma} production by NK and CD4+NKT cells regulated by the Src kinase Fgr
Blood, May 1, 2006; 107(9): 3647 - 3655.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Chiesa, M. Mingueneau, N. Fuseri, B. Malissen, D. H. Raulet, M. Malissen, E. Vivier, and E. Tomasello
Multiplicity and plasticity of natural killer cell signaling pathways
Blood, March 15, 2006; 107(6): 2364 - 2372.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. Caraux, N. Kim, S. E. Bell, S. Zompi, T. Ranson, S. Lesjean-Pottier, M. E. Garcia-Ojeda, M. Turner, and F. Colucci
Phospholipase C-{gamma}2 is essential for NK cell cytotoxicity and innate immunity to malignant and virally infected cells
Blood, February 1, 2006; 107(3): 994 - 1002.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
Y. T. Bryceson, M. E. March, H.-G. Ljunggren, and E. O. Long
Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion
Blood, January 1, 2006; 107(1): 159 - 166.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.